JCM-16021

· ZhaoXiang Bian (sponsor)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JCM-16021, covering 2020-08-19 to 2020-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome [Phase 2, Phase 3]

See pricing